Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

219 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prostanoid therapy for pulmonary arterial hypertension.
Badesch DB, McLaughlin VV, Delcroix M, Vizza CD, Olschewski H, Sitbon O, Barst RJ. Badesch DB, et al. Among authors: barst rj. J Am Coll Cardiol. 2004 Jun 16;43(12 Suppl S):56S-61S. doi: 10.1016/j.jacc.2004.02.036. J Am Coll Cardiol. 2004. PMID: 15194179 Free article. Review.
Beraprost therapy for pulmonary arterial hypertension.
Barst RJ, McGoon M, McLaughlin V, Tapson V, Rich S, Rubin L, Wasserman K, Oudiz R, Shapiro S, Robbins IM, Channick R, Badesch D, Rayburn BK, Flinchbaugh R, Sigman J, Arneson C, Jeffs R; Beraprost Study Group. Barst RJ, et al. J Am Coll Cardiol. 2003 Jun 18;41(12):2119-25. doi: 10.1016/s0735-1097(03)00463-7. J Am Coll Cardiol. 2003. PMID: 12821234 Free article. Clinical Trial.
Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry.
Badesch DB, Raskob GE, Elliott CG, Krichman AM, Farber HW, Frost AE, Barst RJ, Benza RL, Liou TG, Turner M, Giles S, Feldkircher K, Miller DP, McGoon MD. Badesch DB, et al. Among authors: barst rj. Chest. 2010 Feb;137(2):376-87. doi: 10.1378/chest.09-1140. Epub 2009 Oct 16. Chest. 2010. PMID: 19837821
Bosentan therapy for pulmonary arterial hypertension.
Rubin LJ, Badesch DB, Barst RJ, Galie N, Black CM, Keogh A, Pulido T, Frost A, Roux S, Leconte I, Landzberg M, Simonneau G. Rubin LJ, et al. Among authors: barst rj. N Engl J Med. 2002 Mar 21;346(12):896-903. doi: 10.1056/NEJMoa012212. N Engl J Med. 2002. PMID: 11907289 Free article. Clinical Trial.
Efficacy and safety of treprostinil: an epoprostenol analog for primary pulmonary hypertension.
McLaughlin VV, Gaine SP, Barst RJ, Oudiz RJ, Bourge RC, Frost A, Robbins IM, Tapson VF, McGoon MD, Badesch DB, Sigman J, Roscigno R, Blackburn SD, Arneson C, Rubin LJ, Rich S; Treprostinil Study Group. McLaughlin VV, et al. Among authors: barst rj. J Cardiovasc Pharmacol. 2003 Feb;41(2):293-9. doi: 10.1097/00005344-200302000-00019. J Cardiovasc Pharmacol. 2003. PMID: 12548091 Clinical Trial.
Endothelin receptor antagonists in pulmonary arterial hypertension.
Channick RN, Sitbon O, Barst RJ, Manes A, Rubin LJ. Channick RN, et al. Among authors: barst rj. J Am Coll Cardiol. 2004 Jun 16;43(12 Suppl S):62S-67S. doi: 10.1016/j.jacc.2004.02.042. J Am Coll Cardiol. 2004. PMID: 15194180 Free article. Review.
219 results